These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4670478)

  • 1. In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.
    Levison ME; Knight R; Kaye D
    Antimicrob Agents Chemother; 1972 May; 1(5):381-4. PubMed ID: 4670478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro bactericidal effectiveness of four aminoglycoside antibiotics.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1973 Jan; 3(1):87-94. PubMed ID: 4790579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.
    Del Bene VE; Farrar WE
    Antimicrob Agents Chemother; 1972 Apr; 1(4):340-2. PubMed ID: 4670697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of tobramycin, an aminoglycoside antibiotic.
    Dienstag J; Neu HC
    Antimicrob Agents Chemother; 1972 Jan; 1(1):41-5. PubMed ID: 4670427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
    Anderson EL; Gramling PK; Vestal PR; Farrar WE
    Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
    Kluge RM; Standiford HC; Tatem B; Young VM; Greene WH; Schimpff SC; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
    Meyer RD; Young LS; Armstrong D
    Appl Microbiol; 1971 Dec; 22(6):1147-51. PubMed ID: 5002900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing with tobramycin.
    Shadomy S; Kirchoff C
    Antimicrob Agents Chemother; 1972 May; 1(5):412-6. PubMed ID: 4670483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH; Koperski K; Scherf H
    Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
    Kelly MT; Matsen JM
    Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.
    Crowe CC; Sanders E
    Antimicrob Agents Chemother; 1973 Jan; 3(1):24-8. PubMed ID: 4790572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Jan; 11(1):118-21. PubMed ID: 836009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.